Search

everythinglearnresearchcommunity

for

Search:↓

Men with CCCA often face delayed diagnosis and severe hair loss, highlighting the need for earlier recognition and treatment.

Glypican-1 is important for blood vessel growth in hair follicles and could help treat hair loss.

Mutant CDP/Cux protein causes hair defects and reduced male fertility in mice.

Topical calcitriol may reduce hair loss from chemotherapy at higher doses.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

Advancements in understanding, diagnosing, and managing congenital adrenal hyperplasia have improved treatment and long-term outcomes.

A mouse model for studying scleroderma in chronic graft-versus-host disease was successfully created.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

circRNA-1926 helps goat stem cells turn into hair follicles by affecting miR-148a/b-3p and CDK19.

Gonadal biopsy is the best method to diagnose gonadal dysgenesis.

PFD patch helps laser tattoo removal, trichoscopy diagnoses AGA, and serum boosts SOD activity.

The debate on direct-to-consumer pharmaceutical ads continues, with consumers finding them educational and doctors concerned about their impact on patient relationships and medication understanding.

Yorkshire Terriers with Colour Dilution Alopecia have reduced melanin and hair structure issues.

Prednisolone improved symptoms in a woman with Cronkhite-Canada syndrome, but regular screenings are needed due to cancer risk.

Seven new genetic risk areas for prostate cancer were found.

Progeria, a disease that causes early aging, is linked to a gene mutation and helps us understand normal aging.

Early diagnosis and treatment of congenital adrenal hyperplasia are crucial to manage symptoms and prevent complications.

dAR-6–1 is a promising new treatment for hair loss that works better than minoxidil.

Researchers made a cell line that grows quickly and can help with hair growth research.

Improved genetic diagnosis of PCOS can lead to better patient outcomes.

BIVV009 is a safe treatment for bullous pemphigoid that reduces C3 deposition without harmful side effects.

Lipocalin-Type Prostaglandin D2 Synthase (L-PGDS) is a protein that plays many roles in the body, including sleep regulation, pain management, food intake, and protection against harmful substances. It also affects fat metabolism, glucose intolerance, cell maturation, and is involved in various diseases like diabetes, cancer, and arthritis. It can influence sex organ development and embryonic cell differentiation, and its levels can be used as a diagnostic marker for certain conditions.

Researchers created a reliable method to measure dexpanthenol and resorcinol in hair products.

The updated GRADE guidance advises considering context when interpreting variability in research results and introduces tools for assessing subgroup effects.

CO₂ laser surgery successfully healed a dog's chronic paw condition.

Infrared spectral imaging can map hair growth proteins and sugars without staining.

Cronkhite-Canada syndrome can sometimes show unusual colonic adenomatous polyps.

The project aimed to understand how genetic test results affect patients' actions and feelings in dermatology.

Cyclosporin A, a drug, reduces TGF-β2 expression in skin cells, potentially causing excessive hair growth through a process involving the calcineurin/NFAT pathway.

Combining glucocorticoids with immunosuppressants like cyclophosphamide improves remission and reduces relapse in pemphigus patients.